Trial Profile
Comparative Clinical and Economic Outcomes of Ertapenem (ERT) Treated Patients with Infections Caused by AmpC Beta-Lactamase Producing Enterobacteriaceae (AmpC-ENT)
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 22 Dec 2015
Price :
$35
*
At a glance
- Drugs Ertapenem (Primary) ; Cefepime; Ceftriaxone
- Indications Enterobacteriaceae infections
- Focus Therapeutic Use
- 21 Apr 2014 New trial record